MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Behavioral abnormalities"

  • 2019 International Congress

    Successful treatment of Parkinson’s disease-related impulse control disorder with bilateral STN DBS

    T. Stiep, D. Spengler Shpiner, C. Luca (Miami, FL, USA)

    Objective: To present a case of Parkinson’s disease (PD) complicated by impulse control disorder (ICD) which improved following deep brain stimulation (DBS) targeting the bilateral…
  • 2019 International Congress

    Protective and therapeutic activity of Cinnamaldehyde in the mouse model of Parkinson’s disease

    S. Rajput, S. Sinha (New Delhi, India)

    Objective: Objective of our study was to evaluate protective and therapeutic activity of Cinnamaldehyde in the mouse model of Parkinson’s disease. Background: Parkinson’s disease (PD),…
  • 2018 International Congress

    Movement disorder masquerading as seizure disorder

    K. Ganesh (Madurai, India)

    Objective: The main objective of presenting this case report is to emphasise the importance of accurate clinical diagnosis of movement disorder in children which many…
  • 2018 International Congress

    VIT-D and Tics Movement Disorder

    N. Gemawat (Mumbai, India)

    Objective: Tics is common childhood movement disorder, with classified variants , typically begin at around 4-5 years of age but often present later at about…
  • 2018 International Congress

    Acute concomitant presentation of chorea and subacute combined degeneration secondary to vitamin B12 deficiency

    E. Natera, F. Acebrón, A. Sánchez, V. Ros, A. Gómez, F. Ruiz, B. Zarza, C. Estévez, A. Alonso, JC. Martínez-Castrillo, I. Corral (Madrid, Spain)

    Objective: To describe an exceptional presentation of vitamin B12 deficiency. Background: Vitamin B12 deficiency typically presents with subacute combined degeneration (SCD). Extrapyramidal symptoms are rare,…
  • 2018 International Congress

    Neuroprotective role of cinnamaldehyde against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease

    P. Kashyap, S. Gupta (Bihar, India)

    Objective: The present study examined the potential therapeutic effects of CA against 3-nitropropionic acid (3-NP)-induced oxidative stress in a rat model of HD and explored…
  • 2018 International Congress

    REM sleep-related episodes in children with Narcolepsy type 1 after treatment with Sodium Oxybate

    E. Antelmi, F. Pizza, G. Plazzi (Bologna, Italy)

    Objective: We aimed to analyze the effect of Sodium Oxybate (SO) on motor events occurring during nighttime in children affected with Narcolepsy type 1 (NT1).…
  • 2018 International Congress

    Rotenone model of Parkinson’s disease: The dosing options in mice revisited

    M. Raza, N. Zehra, S. Malhi (Karachi, Pakistan)

    Objective: In the present study we have used various dosing protocols to induce the PD-like symptoms with the administration of rotenone in mice. Background: Parkinson's…
  • 2018 International Congress

    Comparative study of the cognitive and behavioral disturbances between progressive supranuclear palsy phenotypes

    A. Horta-Barba, J. Pagonabarraga, S. Martinez-Horta, I. Illán, I. Aracil, J. Pérez-Pérez, B. Pascual, H. Bejr-Kasem, J. Marin, F. Sampedro, M. Botí, C. Izquierdo, A. Campolongo, J. Kulisevsky (Barcelona, Spain)

    Objective: Explore cognitive and behavioural disturbances between subtypes of progressive supranuclear palsy (PSP). Background: Although clinical diagnosis of PSP is based on specific motor symptoms,…
  • 2018 International Congress

    Telepsychiatry for Patients with Parkinson’s disease

    M. Heiry, N. Galifianakis, J. Ostrem, A. Seritan (San Francisco, CA, USA)

    Objective: To demonstrate the feasibility of telemedicine for treatment of psychiatric co-morbidities in Parkinson’s disease and evaluate patient satisfaction with telepsychiatry. Background: Parkinson’s disease (PD)…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley